Universe Pharmaceuticals Adopts Dual-Class Share Structure; Shares Rise 5.5%

Universe Pharmaceuticals (NASDAQ: UPC) has officially announced the implementation of a dual-class share structure, set to take effect on February 13, 2026. Under the new arrangement, the company's authorized share capital of $20,000 will be restructured into two distinct classes of ordinary shares. This includes 1.8 billion Class A ordinary shares and 200 million Class B ordinary shares, aimed at refining the company's equity governance framework. Investors responded favorably to the news, driving the stock price up by 5.52% following the announcement. The strategic move is designed to optimize the company's capital structure and ensure long-term governance stability on the Nasdaq Capital Market. This restructuring highlights the company's commitment to evolving its financial architecture as it continues its operations in the pharmaceutical sector.